BRAF and non-small cell lung carcinoma: The most frequent mechanism is represented by BRAF gene activating mutations, which are present in ~7% of human cancers, including melanoma (40%), colorectal adenocarcinoma (15%), non-small cell lung cancer (NSCLC) (4%) and GB (8%) (7–9),